A/H Share 2025 Barbell
153.全球宏观和资本市场2026展望:大年之后,仍是大年? extends the barbell into a 2026 “still a big year” view. Ricky and 大卫翁 keep A/H exposure as their preferred risk-asset area, with H shares judged higher-odds because they can benefit from China easing, U.S.-China easing, and offshore liquidity, but the source shifts the next-stage question toward China Equity Structural Selection / 中国权益结构分化 and demand/earnings confirmation.
152.关于2026年的四个猜想 extends the barbell into a 2026 flow thesis. China Excess Savings Reallocation / 中国超额储蓄再配置 and China Insurance Funds Equity Allocation / 中国险资入市 can support the dividend and broad equity sides of the China allocation story, but the source keeps this as a conditional liquidity-and-policy channel rather than proof that earnings repair has arrived.
A/H share 2025 barbell is the source’s preferred China-equity structure in Vol.115 全球宏观和资本市场2025展望:短期问题不解决,就没有中期和长期了. Ricky and 大卫翁 describe 2025 A/H equities as potentially easier than 2024 if policy transmission improves, but they split the opportunity into two different valuation logics: cash-flow-heavy Defensive Dividend Assets and future-upside New Quality Productive Forces / 新质生产力 assets.
The concept also includes a staged repair path. The first stage is policy and sentiment improving valuations. The second is leading indicators of profit repair. The third is actual PPI and earnings recovery. That staged view keeps the barbell from becoming a blanket bullish call on all A/H stocks.
vol.124.信息过载后如何保持冷静? | 投资账复盘 adds the post-tariff-panic continuation. 大卫翁 keeps China-related risk assets as one sleeve of 1:1:1 Allocation Anchor, arguing that China still has policy tools and possible offensive upside, but the exposure is balanced against cash-like defense and income-or-hedge assets.
133.全球宏观和资本市场2025年中盘点:中国的三个温差和美国的三个预期差 adds the mid-year checkpoint. Ricky and 大卫翁 say the first-half China asset move was led more by Hong Kong, Chinese ADRs, and new-economy sectors than by broad A-share earnings recovery, so the barbell had made progress mostly through valuation repair and specific growth pockets such as China Biotech Asset Repricing.
143.如何判断一段行情是回调还是结束?| 三季度投资账复盘 adds the third-quarter behavior checkpoint. 大卫翁 says China risk assets continued to benefit from policy, AI, outbound-business, and foreign-underweight narratives, but he still rebalanced toward dividend-related exposure after strong gains because the portfolio was meant to remain an allocation system rather than a pure bull-market chase.
Key Claims
- The dividend side is supported by falling risk-free rates, market-value management, and better shareholder-return behavior, but still needs payout and governance checks.
- The new-productivity side offers policy and technology upside, but much of the value depends on future success probability.
- The source is more comfortable with ordinary investors using combinations, indexes, ETFs, or active funds than trying to chase every theme directly.
- The A/H bullish case can be falsified if short-term fiscal support is too weak or medium-term reform direction becomes unclear again.
- External shocks can create risk-off selloffs, but the source argues the core A/H logic remains China-centered if domestic policy transmission is intact.
- The barbell is not a no-risk structure; it is a way to separate cash-flow anchors from option-like long-term exposure.
- Vol.124 adds that the China-equity sleeve can remain offensive without becoming the whole portfolio.
- Episode 133 adds that Hong Kong can lead a China bull phase before A-shares follow, but the source still requires later profit and demand confirmation before calling the repair complete.
- Episode 143 adds that even when the barbell works, rebalancing back toward role-defined sleeves can be preferable to letting growth-side gains redefine the whole portfolio.
Connections
- Defensive Dividend Assets, New Quality Productive Forces / 新质生产力, and Barbell Strategy — core structure.
- Policy-Driven Market Rally, China Policy Easing Pivot, and Short-Term Demand Before Long-Term Reform — policy and macro preconditions.
- A-Share Valuation Indicators, AH Share Discount Repricing, Hong Kong Market Structure, and Hong Kong Stock Connect — A/H market and valuation context.
- Fact/Future Asset Pricing — valuation distinction behind the two sides.
- Investment Risk Management and Portfolio Suitability — ordinary-investor implementation guardrails.
- 1:1:1 Allocation Anchor, Sleep-Well Portfolio Test / 睡眠理论, and Investment Liquidity Tradeoff — vol.124’s broader portfolio anchor around the China-risk sleeve.
- Hong Kong Tech Repricing, China Biotech Asset Repricing, and China Macro Temperature Gaps / 中国宏观温差 — episode 133’s mid-year update to where China-equity repricing appeared first.
- Market Pullback vs Trend End, 1:1:1 Allocation Anchor, and Drawdown Psychology — episode 143’s Q3 rebalancing and bull-market behavior extension.